City

Hangzhou (1)

Nanjing (1)

Padova (1)

Condition

Pharmacogenomic Drug Interaction (3)

Cardiovascular Diseases (1)

Depressive Disorder (1)

Multidrug Resistant Bacterial Infection (1)

Polymyxin B (1)

Type 2 Diabetes (1)

Ventilator-associated Pneumonia (1)

Overall Status

Recruiting (2)

Completed (1)

Sign in for free

Phase

n/a (2)

Sponsor

Mario Luca Morieri (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

Southeast University, China (1)

Collaborator

Intervention

fenofibrate 145 mg (1)

nebulized polymyxin b (1)

pharmacogenomic testing (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

pharmacogenomic drug interaction

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Epithelial Lining Fluid and Blood Pharmacokinetics and

Recruiting

Polymyxin B
+3 more

nebulized polymyxin B

Nanjing, Jiangsu, China

Zhongda Hospital Affiliated to Southeast University

Oct 7, 2023

Depressive Disorder, Pharmacogenomic Drug Interaction Trial in Hangzhou (pharmacogenomic testing)

Completed

Depressive Disorder
Pharmacogenomic Drug Interaction

pharmacogenomic testing

Hangzhou, Zhejiang, China

Second Affiliated Hospital, School of Medicine, Zhejiang Univers

Jul 17, 2023

Type 2 Diabetes, Cardiovascular Diseases, Pharmacogenomic Drug Interaction Trial in Padova (Fenofibrate 145 mg, Placebo)

Recruiting

Type 2 Diabetes
+2 more

Fenofibrate 145 mg
Placebo

Padova, Padua, Italy

University Hospital of Padova

Sep 13, 2022